Follow the 노보믹스 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 노보믹스 has logged 9 insider filings. The latest transaction was disclosed on 28 November 2024 (Purchase). Among the most active insiders: 허용민. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
9 of 9 declarations
Novomix es una empresa que cotiza en el mercado XKRX, especializada en el sector de la salud y farmacéutico. Se centra en el desarrollo y la comercialización de productos farmacéuticos innovadores.